Healthcare giant CVS Health announced Nov. 4 plans to separate into two independent, publicly traded companies.
Based in Woonsocket, R.I., CVS said the split would create:
- CVS Health: A healthcare solutions company, comprising Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health.
- David Joyner, currently chairman and CEO of CVS Health, will retain those titles and lead this company.
- CVS Pharmacy: A national retail pharmacy and community healthcare company, comprising approximately 9,000 CVS pharmacies, mail pharmacy, MinuteClinic (including virtual care) and the Health100 technology services business.
- Prem Shah, currently group president of CVS Health, will be the CEO of CVS Pharmacy.
CVS operates more than 340 locations across New Jersey, according to the company’s website.
The move follows a comprehensive strategic review by the company’s board of directors, CVS said. Structured as tax-free for U.S. federal income tax purposes, the split is expected to be completed in the first half of 2028, subject to customary conditions.
Upon completion, CVS Health shareholders will own shares in both companies.
Cutting costs
In 2021, CVS announced a three-year retail optimization plan. By October 2024, it ultimately closed about 900 stores nationwide. That included 15 stores in New Jersey.
The same month it completed the store-closure plan, the company announced massive layoffs nationwide as part of campaign to cut $2 billion in costs. The 2,900 eliminated positions included 111 at its corporate office in Florham Park.
As for its latest decision, the company said the move “accelerates our strategy” to “deliver best-in-class execution, transform consumer experiences, be the partner of choice and harness enterprise capabilities.”
“Our history is defined by proactively evolving to stay ahead of what’s next in healthcare, and in today’s environment, that means delivering more affordability, greater access, and a simpler experience,” Joyner said in the announcement.
He added that the company has “made meaningful progress” over the past two years toward its goals.
Goldman Sachs & Co. LLC is serving as lead financial advisor and strategic advisor to the company. Consello is also serving as financial and strategic advisor to the company. Wachtell, Lipton, Rosen & Katz is serving as legal counsel to the company.
Revenue increase
The day of the announcement, CVS also released its third quarter 2026 results for the three months ended Sept. 30, 2026. The company noted total revenues increased to $108.4 billion, up 5.4% year over year.
CVS serves an estimated 37 million people through its products and services.
The post CVS to split into two publicly traded companies appeared first on NJBIZ.

